Literature DB >> 28169931

Bowel Function and Quality of Life After Transanal Endorectal Pull-through for Hirschsprung Disease: Controlled Outcomes up to Adulthood.

Malla I Neuvonen1, Kristiina Kyrklund, Risto J Rintala, Mikko P Pakarinen.   

Abstract

OBJECTIVE: The aim of this study was to define controlled outcomes up to adulthood for bowel function and quality of life (QoL) after transanal endorectal pull-through (TEPT) for Hirschsprung disease (HD). SUMMARY OF BACKGROUND DATA: Although TEPT is the surgical standard for HD, controlled long-term follow-up studies evaluating bowel function and QoL are lacking.
METHODS: Patients aged ≥4 years operated for HD with TEPT between 1987 and 2011 answered detailed questionnaires on bowel function and QoL [Pediatric Quality of Life Inventory (PedsQL, age <18 yrs) or Gastrointestinal Quality of Life Index (GIQLI) and SF-36]. Patients were compared with 3 age- and gender-matched controls each randomly selected from the general population.
RESULTS: Seventy-nine patients (64%) responded (median age 15, range 4-32 years; 86% rectosigmoid aganglionosis). Compared with controls, patients reported impairment of all aspects of fecal control (P < 0.05), except constipation. In cross-section, 75% of patients were socially continent (vs 98% of controls; P < 0.001). Soiling, fecal accidents, rectal sensation, and ability to withhold defecation improved with age to levels comparable to controls by adulthood (P = NS), but stooling frequency remained higher in 44% of patients (P < 0.05 vs controls). PedsQL domains in childhood were equal to controls (P = NS), except for proxy-reports of sadness/depression. Adults exhibited lower emotional scores, limitation of personal, and sexual relationships (P < 0.05).
CONCLUSION: Compared with matched peers, significant impairment of fecal control prevails after TEPT in HD patients during childhood, but symptoms diminish with age. Although overall QoL appeared comparable to controls, impairment of emotional and sexual domains may prevail in adulthood.

Entities:  

Mesh:

Year:  2017        PMID: 28169931     DOI: 10.1097/SLA.0000000000001695

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  High Levels of Interest in Reproductive Genetic Information in Parents of Children and Adults With Hirschsprung Disease.

Authors:  Courtney D Berrios; Aravinda Chakravarti; Barbara B Biesecker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 2.  Pediatric enteric neuropathies: diagnosis and current management.

Authors:  Maggie L Westfal; Allan M Goldstein
Journal:  Curr Opin Pediatr       Date:  2017-06       Impact factor: 2.856

3.  Hirschsprung's disease in the laparoscopic transanal pull-through era: implications of age at surgery and technical aspects.

Authors:  Go Miyano; Masahiro Takeda; Hiroyuki Koga; Manabu Okawada; Nana Nakazawa-Tanaka; Junya Ishii; Takashi Doi; Geoffrey J Lane; Tadaharu Okazaki; Masahiko Urao; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

4.  Clinical outcomes and risk factors for postoperative complications in children with Hirschsprung's disease.

Authors:  Tingting Gao; Weijue Xu; Qingfeng Sheng; Ting Xu; Wei Wu; Zhibao Lv
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Bowel dysfunction following pullthrough surgery is associated with an overabundance of nitrergic neurons in Hirschsprung disease.

Authors:  Lily S Cheng; Dana M Schwartz; Ryo Hotta; Hannah K Graham; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2016-08-09       Impact factor: 2.545

Review 6.  Long-term results of transanal pull-through for Hirschsprung's disease: a meta-analysis.

Authors:  J Zimmer; C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2016-07-06       Impact factor: 1.827

Review 7.  Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee.

Authors:  Akemi L Kawaguchi; Yigit S Guner; Stig Sømme; Alexandria C Quesenberry; L Grier Arthur; Juan E Sola; Cynthia D Downard; Rebecca M Rentea; Patricia A Valusek; Caitlin A Smith; Mark B Slidell; Robert L Ricca; Roshni Dasgupta; Elizabeth Renaud; Doug Miniati; Jarod McAteer; Alana L Beres; Julia Grabowski; Shawn D St Peter; Ankush Gosain
Journal:  J Pediatr Surg       Date:  2021-03-28       Impact factor: 2.549

8.  Interest of Anorectal Manometry During Long-term Follow-up of Patients Operated on for Hirschsprung's Disease.

Authors:  Viet Q Tran; Tania Mahler; Patrick Bontems; Dinh Q Truong; Annie Robert; Philippe Goyens; Henri Steyaert
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

9.  Pan-enteric neuropathy and dysmotility are present in a mouse model of short-segment Hirschsprung disease and may contribute to post-pullthrough morbidity.

Authors:  Sukhada Bhave; Emily Arciero; Corey Baker; Wing Lam Ho; Richard A Guyer; Ryo Hotta; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2020-04-17       Impact factor: 2.545

10.  Optimal timing for Soave primary pull-through in short-segment Hirschsprung disease: A meta-analysis.

Authors:  Maggie L Westfal; Ongoly Okiemy; Patrick Ho Yu Chung; Jiexiong Feng; Changgui Lu; Go Miyano; Paul Kwong Hang Tam; Weibing Tang; Kenneth Kak Yuen Wong; Atsuyuki Yamataka; Richard A Guyer; Daniel P Doody; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2021-07-21       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.